Compare Amylx Pharmaceuticals Inc (AMLX) vs D R Horton Inc (DHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs D R Horton Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while D R Horton Inc trades at $151.45 (market cap $42.18B). The key difference: D R Horton Inc is far larger — about 16× Amylx Pharmaceuticals Inc's market cap, and D R Horton Inc pays a 1.19% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | DHI | |
|---|---|---|
Market Cap | $2.64B | $42.18B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $184.04 |
52-Week Low | $7.82 | $132.53 |
Enterprise Value | $2.39B | $47.28B |
Dividend Yield | — | 1.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →
